About Beckman Coulter, Inc.
Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.
Forward Looking Statements
This press release contains forward-looking statements, including
statements regarding the contribution of the acquired technology to Beckman
Coulter's R&D and product development capability. These statements are
based on current expectations and assumptions. Actual results could differ
materially from those anticipated by these forward-looking statements as a
result of a number of factors, some of which may be beyond Beckman
Coulter's control. Factors that affect the development of new technologies
are described in Beckman Coulter's 10-K report filed with the SEC on
February 26, 2007 and its 10-Q reports and other SEC filings.
Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter
Corporate Communications Investor Relations
(714) 773-7964 (714) 773-7620
|SOURCE Beckman Coulter, Inc.|
Copyright©2007 PR Newswire.
All rights reserved